Enforce Medical Technologies sp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-09-11
Share capital
576,100.00 PLN
Average employment (people)
10 (2026)
Activity description

Enforce Medical Technologies offers prosthetic feet, the ENFORCE Dynamic Foot and the ENFORCE Bionic Foot. The products are designed to provide a natural walking feel and are described as competitively priced.

Registered address
ul. Szelągowska 45A, 61-626 Poznań, Poland
Opening hours
Mon–Fri, 8:00–16:00
Email
Phone
Social media
Electronic delivery address
AE:PL-80227-60901-EDUAS-25

Financials

Revenue history (in k)

From the notes

Profit allocationNo decision
Grants$162,891

Filing timeliness

Financial statements were filed on time, on average 5 days early.

  • 202609/11/2026
  • 202507/11/2025
  • 202406/11/2024
  • 202310/11/2023
  • 202214/11/2022
  • 202112/11/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2026.

Top 16%
City · Poznań2,954 / 11,708
Top 25%
Voivodeship · Wielkopolskie10,311 / 30,871
Top 33%
Country · Poland93,617 / 297,266
Top 31%

Results vs industry

Revenue
This companyUSD 1.01mMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD 90.06kMedianUSD 68.58AverageUSD 83.05k
Operating costs
This companyUSD 796.92kMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 2.36mMedianUSD 120.25kAverageUSD 3.90m

Offer

Websites

The sites are available in: Polish, English and ua.

  • enforcemed.plENforce Medical Technologies » www
    WordPress 6.9Google AnalyticsGoogle Tag ManagerPolylangApache
  • protezujemy.plProtezujeMY
    WebflowApache

Public procurement

1 tender recorded as contractor, with a total value of $134,198.

SubjectAmount
Purchase of medical equipment and prosthetic components forming parts of a modular below-knee prosthesis, using electronics and sensors to imitate natural foot movements
$134.2K

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Provision of medical deviceswielkopolskie1USD 0.00

Authorized Representatives

Sebastian Marcin But age 29 – Management Board Member
Piotr Krzysztof Rajewski age 46 – President of the Management Board

Manner of representation

The following are authorised to sign and make declarations on behalf of the company: 1. in the case of a one-person management board, the sole member of the management board acting independently; 2. in the case of a multi-member management board, at least two members of the management board acting jointly, including the Vice-President of the Management Board, if one has been appointed.

Supervisory board

Marcin Grzegorz Katański age 57 – Supervisory Board Member
Patryk Stanisław Urban age 44 – Supervisory Board Member
Piotr Zygmunt Pażucha age 54 – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
3,922$52,971.3734.0392%
4,864$65,694.2242.2149%
1,216$16,423.5510.5537%
1,520$20,529.4413.1922%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-09-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

9 public aid cases recorded, with a total value of $1,886,344.

PurposeGross amount
Aid for research and development projects: experimental development
$406.6K
De minimis aid (in accordance with Commission Regulation 2023/2831)
$14,749
Aid for research and development projects: industrial research
$418.7K

European Funds

4 projects co-financed from European Funds recorded, with total EU co-financing of $1,578,890.

ProjectEU co-financing
Conducting development and validation work on a multi-variant knee prosthesis: innovative solutions to improve functionality and safety
$391.7K
Development of an innovative bionic knee prosthesis
$473.4K
Development of an innovative, individually fitted vacuum prosthetic socket
$394.8K

Competitors

Name
Aether Biomedical sp. z o.o.
Ortocentrum sp. z o.o.
Ortotomas sp. z o.o. + limited partnership
Ambio P.S.A.
Orto-Prot Kołodyńscy sp. z o.o.
Ortoconcept sp. z o.o.
LAB przy Zębie sp. z o.o.
Salon Ortopedyczny Or-Tech sp. z o.o.
Glaze Prosthetics sp. z o.o.
Vbionic sp. z o.o.

Change history

DateEvent
2024-06-11Share capital increase
2024-06-11PKD change
2021-04-13Share capital increase
2019-11-29Share capital increase
2018-09-27PKD change

FAQ

Last updated: 2026-11-09